Navigation Links
Finland Biotech Delegation Visits Sundia

SHANGHAI, May 20 /PRNewswire-Asia/ -- A Finland Biotech Delegation visited Sundia MediTech Company, a leading pharmaceutical R&D outsourcing CRO service company in Shanghai, China, in April.

The 9 members of the delegation are from Finnish Funding Agency for Technology and Innovation (Tekes), and three Finnish leading Biotech Companies.

Dr. Xiongwei Shi, Executive Vice President of Sundia MediTech Company, hosted the group and presented to the guests about Sundia's business activities and development strategy. Dr. Pauli Saarenketo, Manager of Tekes, presented Tekes' organization and its functions, especially its Pharmaceutical programs including the Finnish-Chinese Pharmaceutical Collaboration (Research) Program. Delegates from 3 Finnish companies also presented their companies' business as well as CRO needs. Tigermed Consulting Ltd., a strategic alliance partner of Sundia, participated in the meeting.

The Finnish delegates highly praised Sundia's fast growth in recent years, and were very much impressed by Sundia's CRO service capabilities and its state-of-the-art facilities. The hosts and the guests expressed a strong desire for future collaborations.

About Sundia MediTech

Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 5 years, Sundia has built a strong reputation as a leading CRO service company in China.

About Tekes Pharma Program

The extensive goal of the Tekes programme Pharma - Building Competitive Edge is to promote the international competitiveness of the Finnish pharmaceutical industry. The programme focuses on the development of operational models and methods to intensify activity and networking within the industry. The creation of new operational models is promoted through networking between pharmaceutical R&D, diagnostics, and clinical research.

    For more information, please contact:

     Victor Lin
     Sundia MediTech Company
     Tel:   +86-158-0086-7006

     Pauli Saarenketo
     Pharma Programme Manager Tekes
     Tel:   +358-10-60-22538

    Sino - Finnish Call for Proposals for Joint R&D Projects

SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Finland Seeks Systemic Changes in Health Care
2. Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden
3. Karolinska Development Invests in EvoStem Finland Oy
4. World research leaders gather in Finland to accelerate the development of bioactive paper
5. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
6. BioTech Firm Decodes Current Swine Flu BioMarkers
7. BioTech Medical Well-Positioned to Immediately Respond to Swine Flu Emergency with SDC-Based SpectraSan 24 Disinfectant
8. David Kaye Launches a New Facilities Services Company to Assist the Growing Biotechnology Business in Maryland
9. PRA Hosts Biotech 2009 - Challenges and Opportunities in R&D
10. American Biotech Labs(R) Obtains FDA Approval for New Wound Care Gel Product
11. New Sports Supplement Company to Partner with Indus Biotech
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology: